1CONTENTS
4
, . .
, ““ . “ , , “” . , .
.
Disclaimer
5
6
&

8 : Cosmetics : Pharmaceuticals : Health supplements
Pharmascience
Korea
1,110,784 3,382,564 314,068 145,731 65,411
52.6% 89.3% 78.2% 54.4% 61.9%
: (2018 )
(: , )
Kolmar BNH Stable marketing
Sales Ranking of the health functional food industry in domestic

1 8,503 33.7 4.0 8,176 7,598
2 () 1,701 6.7 29.4 1,314 1,095
3 1,242 4.9 103.1 612 426
4 954 3.8 2.7 929 998
5 732 2.9 (3.1) 755 670
6 570 2.3 (9.2) 628 570
7 709 2.8 9.4 648 601
8 637 2.5 (3.6) 660 626
9 576 2.3 2.3 563 554
10 516 2.0 20.3 429 410


( :)
1 11,096 44.0 10,358 46.3 9,900 46.6 6,943 38.1
2 3,226 12.8 2,450 11.0 2,357 11.1 3,195 17.5
3 2,994 11.9 2,174 9.7 1,903 9.0 1,579 8.7
4 2,484 9.8 2,259 10.1 1,843 8.7 2,079 11.4
5 823 3.3 1,042 4.7 1,091 5.1 705 3.9
20,623 81.8 18,283 81.8 17,094 80.5 14,501 79.6
2015
1 699 28.5 20.1 582 533 714
2 543 22.2 140.3 226 249 255
3 210 8.6 8.2 194 145 103
4 207 8.4 209.0 67 98 266
5 137 5.6 (25.9) 185 - -
1,796 53.1 27.5 1,254 1,025 1,338


, ,
2. - -
1. - EGF - Dormin - -
Hit Products Absolute CellActive Skincare
27
50 55
60 70

()
KBH-14F-K-01 / • ,
KBH-16F-G-04 / • / ‘21
KBH-15F-G-03 / • ,
KBH-14F-G-02 / • / ‘20
KBH-17F-C-08 / • (‘19) / ’21
KBH-17F-C-09 / , • (‘19) / ’21
KBH-17F-C-10 / , • (‘20) / ‘22
KBH-17F-C-12 , / • ()(‘19) / ‘22
KBH-17F-C-13 / • (‘20) / ’22
KBH-17F-C-14 / • /’21
KBH-18F-K-17 / •
KBH-16F-A-05 / , • /’20
KBH-17F-A-11 / • /(‘19) / ‘21
KBH-18F-A-19 / • ()(‘20) / ‘22
KBH-19F-A-01 / • NDI / ‘20
C&D
30

Made in China
Made in Australia, New Zealand
Made in USA, Canada
R&D
22,981( 113.8) 17,135
USD 42,000,000
1
Entry to Chinese marketEntering China MarketEntry to Chinese market
34
USD 16,000,000
1
CAPA
Entering China MarketEntry to Chinese market
35

1. ( : )
FY 17 18. 03 18. 06 18.09 18.12 FY 18 19.03 19.06 19.09 Y_Y Q_Q
1,660 494 495 480 543 2,013 571 673 636 33% -5%
1,458 433 432 415 429 1,708 473 583 502 21% -14%
202 62 64 65 114 305 98 90 135 107% 49%
1,326 344 303 293 404 1,344 357 348 325 11% -7%
1,020 252 247 221 269 989 265 269 220 -1% -18%
306 91 57 72 135 355 92 79 105 47% 33%
/ 3 1 1 1 1 4 1 1 1 29% 66%
() 2,989 839 800 774 949 3,361 929 1,022 962 24% -6%
124 64 28 46 63 200 73 116 70 53% -40%
452 156 134 148 189 627 181 188 168 13% -11%
() -189 92- 52- 73- 108- 325- 117- 163- 119- 62% -27%
() 3,376 966 909 895 1,093 3,864 1,066 1,164 1,081 21% -7%
2. ( : )
FY 17 18. 03 18. 06 18.09 18.12 FY 18 19.03 19.06 19.09 Y_Y Q_Q
() 431 128 132 122 142 524 140 165 154 26% -7.0%
() 14.4% 15.3% 16.5% 15.7% 14.9% 15.6% 15.0% 16.2% 16.0% 2% -1.2%
() 488 145 137 137 166 585 167 198 174 27% -12.0%
() 14.4% 15.0% 15.1% 15.3% 15.2% 15.2% 15.7% 17.0% 16.1% 5% -5.2%
2019 3() 962 24%, 26% 154
2019 3() 1,081 21% , 27% 174
1. 636(+33.0%, Y_Y) 3. ( 13)
- 109% - 3Q (+47% Y_Y)
- 3Q Y_Y 35% , 3Q Y_Y 32% - 3Q (+107% Y_Y)
- 3Q Y_Y 58%
2. 325(+11% Y_Y)
- 3Q Y_Y 48%
- The Fame 53set('19.3 )
<2019 3 >
IR